As of February of 2022, subscribers will be able to view and filter individual regulatory alerts per region. If you want to get our alerts compilations, visit our alerts Round-up section.
7th December 2022
Morocco: Mohammed El-Krouj, director general of the National Agency for the Regulation of Cannabis Activities, told press that the agency intends to embark on a training programme for cannabis farmers before the end of December to prepare them for the first growing season since the legalisation of hemp – defined as cannabis with 1% THC or less. Farmers will be trained in growing, cultivating, watering, collecting, drying, and all other farming activities related to cannabis.
21st November 2022
5th October 2022
Morocco: The National Agency for the Regulation of Cannabis Activities (Anrac) announced yesterday that it had issued ten licences for the cultivation, manufacturing, marketing, and export of cannabis products, press reports. The agency said it “continues to explore the opportunities offered by the cannabis market in order to develop this sector and promote the transformation of farmers from illicit activity towards legal, sustainable and income-generating cultivation”.
3rd October 2022
6th September 2022
South Africa: The Western Cape High Court has dismissed a company director’s application to decriminalise cannabis “grow clubs”, press reports. The court said that recognising the grow club model, in which a private club grows cannabis on behalf of others, would contravene the Drugs Act. The Constitutional Court decriminalised the possession and cultivation of cannabis for personal home use in 2018.
27th July 2022
Zimbabwe: The Medicines Control Authority has invited all licensed cannabis and hemp producers, manufacturers, importers, exporters and retail pharmacists to apply to sell medical CBD products as complementary medicines. Applicants will have to provide product samples and accept official inspections at production sites. Zimbabwe legalised medicinal cannabis in 2018, but its use is still limited.
20th June 2022
South Africa:Written comments can be sent to the Presidency’s Office until 27th June on a draft plan to bring investments into the country. The draft recognises cannabis as a traded commodity and concludes that medicinal cannabis is more viable to pursue at an industrial scale than recreational cannabis. It also stresses the need for a regulatory framework for medicinal cannabis.
14th June 2022
South Africa: President Cyril Ramaphosa has appointed former trade and industry deputy director Garth Strachan as policy head to help develop the South Africa’s hemp and cannabis industry in cooperation with the Department of Agriculture, press reports. Strachan has spoken in favour of responsible adult use and a regulatory framework for medicinal cannabis and hemp that protect small farmers in rural areas.
3rd June 2022
25th May 2022
South Africa: The parliamentary Committee of Justice and Correctional Services yesterday held a public hearing on the amendments to the Cannabis for Private Purposes Bill, giving interested parties the chance to put their points across. A majority criticised the bill for poorly addressed medicinal and commercial clauses, while the issue of legalising cannabis for religious purposes was also addressed. The bill has been under consideration by the National Assembly since September 2020.
21st April 2022
South Africa: The parliamentary Portfolio Committee on Justice and Correctional Services is considering amendments to the Cannabis for Private Purposes Bill, which would introduce a clear distinction between cannabis and hemp. The committee is inviting interested parties to make written submissions with proposals by 13th May. The bill has been under consideration by the National Assembly since September 2020.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.